Background: The limbal area of the corneal stroma has been identified as a source of
Introduction
Corneal blindness is one of the leading causes of treatable vision loss worldwide [1] . Trauma to the cornea can occur from a wide range of environmental factors including chemical agents, thermal and mechanical injuries, surgical intervention, and microbial infection [2, 3] .
Specialised cellular and structural organization is responsible for corneal transparency essential for normal vision [4] [5] [6] . Due to this, the cornea poses unique therapeutic challenges.
Chronic donor shortages, tissue quality issues, and complications with immune rejection have propelled the development of regenerative medicine strategies for the cornea. These new treatments include the development of stem cell therapies for the treatment of ocular surface disorders.
The stroma of the cornea contains a population of cells known as keratocytes [7] , which under normal healthy conditions remain quiescent and exhibit a dendritic morphology with extensive intercellular contacts [8, 9] . Keratocytes act to maintain the structure and transparency of the stroma by producing and maintaining extracellular matrix (ECM)
proteins, such as collagen and proteoglycans [10] [11] [12] . Markers traditionally used to identify the keratocyte phenotype include aldehyde dehydrogenase (ALDH), keratocan, CD133 and, as originally identified by our group, CD34 [13] [14] [15] .
Keratocytes can be isolated from the stroma using collagenase treatment for ex vivo culture.
However, once transferred to tissue culture plastic, the cells differentiate, and alternative cell populations emerge, dependent on the culture environment [16] [17] [18] . The extracted stromal cells "activate" and take on a fibroblastic phenotype [19, 20] . In vivo, this "activation" is associated with response to injury, as the keratocytes adjacent to the wound begin to exhibit morphological characteristics of fibroblasts and commence tissue remodelling [5, 8] . In severe injuries or later stages of remodelling, a myofibroblast phenotype is adopted, which actively secretes contractile ECM components, such as α-smooth muscle actin (α-SMA). This can cause scar formation and loss of corneal transparency [8, 21] .
In vitro, keratocytes extracted from the limbus, have been shown to display characteristics of multipotent mesenchymal stromal cells (MSC) [20, 22] , that after several passages in a certain medium, conform to a criteria stipulated by the International Society for Cellular Therapy (ISCT) [18, 23] . The extracted corneal stroma-derived stem cells (CSSC) express MSC-associated cell surface markers such as CD29, CD73, CD90 and CD105, and possess the ability to differentiate down the osteogenic, chondrogenic and adipogenic lineages in vitro [18, 24] . Therefore, it has been hypothesized that the limbal keratocyte is an MSC progenitor found in the corneal stroma [18, 25] . A specific population of CSSC that can be identified by side population isolation has also been described that is believed to be a keratocyte progenitor [26] .
Cells extracted from the corneal stroma have previously been cultured under a number of different conditions, with the intention of either retaining keratocyte phenotype or promoting a stem cell phenotype. Traditionally, keratocytes have been cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) [20, 27, 28] , however this has been shown to produce sub-optimal culture conditions for the production of MSC [24] . Researchers have now expanded the repertoire of media that has been used for the culture of corneal stromal cells but few comparative studies between media have been performed. Culture in medium containing serum, of varying concentrations, is usually preferred. Serum has advantages as it provides a source of attachment and growth factors, allowing proliferation and rapid expansion of the cells. However, the presence of serum, or more specifically growth factors present in serum, such as transforming growth factor-β1
(TGF-β1), are reported to cause fibroblastic or myofibroblastic differentiation, characterized by a fusiform morphology and protein markers such as α-SMA [29, 30] and CD90 [31] along with the loss of keratocyte markers [5, 16] . Moreover, the addition of serum has been used to deliberately generate corneal fibroblasts rather than keratocytes [32] , however, most researchers would prefer an undifferentiated/inactive phenotype. Cultures that contain a lower percentage of serum, such as 2% (v/v), retain a keratocyte phenotype more effectively, but have much lower proliferation rates [33] . It has also been suggested that serum-free growth media developed for other cell types might also be suitable, such as the use of keratinocyte serum free medium (K-SFM) [34] . Changing the basal medium from DMEM to medium 199 (M199) or DMEM/F12, which contain a greater proportion of other components such as amino acids and nucleotides leads to the generation of a population of MSC or MSC-like cells [23, 35] . The use of M199 with the addition of 20% FBS to culture keratocytes, generates MSC that adhere to ISCT criteria [18] . Some researchers have cultured cells in media containing recombinant growth factors such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF) and leukaemia inhibitory factor (LIF), in lieu of serum [32, 36, 37] , in order to get a cell phenotype more indicative of a pluripotent stem cell. While this may prove more easily translatable to the clinic compared to serum, the addition of recombinant growth factors, both in research and clinically, can be costly. In addition, keratocytes express CD34 in vivo [14, 15] 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Isolation and culture of primary human corneal stromal stem cells
Human corneal stromal stem cells (CSSC) were isolated from corneal rims, using a modification of a previously described method [23] . Excess sclera was removed and the epithelium and endothelium detached by gentle scraping. Remaining stromal tissue was divided into small pieces and digested in 1 mg/mL collagenase Type IA (Sigma Aldrich, Gillingham, UK) for 7 hours at 37°C. Digests were filtered through a 40 µm cell strainer before being centrifuged and resuspended in appropriate medium. CSSC were continually cultured in one of seven media types (table 1) . CSSC from each donor were separated between all media, to allow for a true comparison of media effects, without donor-to-donor variation. Cells in all media were cultured on surfaces coated with 0.1% (v/v) gelatin (Sigma Aldrich) and incubated in a humidified environment at 37°C, 5% (v/v) CO 2 , with the respective medium changed every 2-3 days. Cells were passaged using treatment with TrypLE™ Express dissociation reagent and seeded at 3,000 cells/cm 2 (Life Technologies, Paisley, UK). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Cell proliferation and viability

Fluorescent immunocytochemistry
Cell samples for immunocytochemistry were cultured in gelatin-coated glass chamber slides Immunocytochemistry was quantified using Image J software version 1.46r. Total number of cells was determined using DAPI images. Image was converted to binary, a watershed was applied and the number of particles analysed, to calculate the number of stained nuclei. The number of antigen-positive cells were then determined manually using the inbuilt cell counter plugin, and a percentage of positive stained cells calculated.
Microscopy and imaging
Phase contrast imaging was performed on a Leica DM-IRB inverted microscope, and images captured with a Hammatsu digital camera and Volocity imaging software (Improvision, Coventry, UK). Fluorescent immunocytochemistry samples were cultured on glass chamber slides and viewed using an upright fluorescence microscope (BX51, Olympus, Southend-onSea, UK) with images captured with a black and white camera (XM-10, Olympus) and Cell^F software (Olympus).
Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR)
Cells were lysed at P2 and the lysate was homogenized using QIAshredder columns (Qiagen, Manchester, UK). Total RNA was extracted using an RNeasy mini kit (Qiagen) according to manufacturer's instructions. RNA quantity was measured using a NanoDrop spectrophotometer. 1 µg of RNA was transcribed into single stranded cDNA using 
Differentiation of CSSC to a keratocyte phenotype
CSSC were grown in different media to P2 and subsequently seeded in 6-well plates and glass chamber slides at 20,000 cells/cm 2 . Cells were maintained in their respective culture media for 3 days before being changed to keratocyte differentiation media for 21 days.
Keratocyte differentiation media consisted of DMEM/F12 supplemented with 50 µg/mL ascorbate 2-phosphate (Sigma-Aldrich), 10 µg/mL human insulin, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite (combination, Life Technologies), 1% non-essential amino acids (Life Technologies), 10 ng/mL bFGF (Life Technologies) and 20 ng/mL gentamicin, 0.5 ng/mL amphotericin B (Life Technologies). Non-differentiated controls were maintained in their culture media. 
Statistical Analysis
Results
Effect of different media on proliferation of CSSC
Effects of the seven media on CSSC proliferation and viability were tested at P0 (figure 1).
CSSC proliferation was slow in standard DMEM over 10 days (figure 1b). Considerably higher proliferation rates were seen in M199 (figure 1c), SCM (figure 1d) and EGM ( figure   1e ). However, in EGM, viability dropped after day 7, when the cells reached confluence.
Cells cultured in MethoCult (figure 1f) adhered to the bottom of the well, despite the semisolid medium and divided slowly, not proliferating significantly until after day 7. Cells in K-SFM did not proliferate at all, but there were still viable cells at day 10. The StemPro-34 medium did not support CSSC proliferation, as there were no viable cells adhered to the plate by day 7.
Effects of different media on morphology of CSSC
Effects of the seven initial media types were compared by imaging CSSC morphology at P0, CD34, THY1 and PAX6 mRNA level was significantly higher in SCM than in any other medium. For CD34 and THY1 there were no other significant differences in mRNA levels between DMEM, M199, EGM and MethoCult. POU5F1 was downregulated in MethoCult compared to DMEM, but no differences were seen between the other media. PAX6 was downregulated in M199, EGM and MethoCult, when compared to DMEM.
Effect of different media on mRNA expression of CSSC
Effect of differentiation on keratocyte differentiation
CSSC that had been cultured in different media up to P2 were changed to a serum-free keratocyte differentiation media for 21 days. Immunocytochemistry and RT-qPCR were performed to assess levels of differentiation compared to non-differentiated controls ( figure   8 ). Immunocytochemistry showed increased levels of ALDH3A1 in all media ( fig. 8A vi-x) .
However, CSSC, in SCM, EGM and MethoCult appeared to contain higher levels of 8C vi-x) . However, SCM controls also contained some cells that stained for CD34. RT-qPCR showed that ALDH3A1 was significantly increased in differentiated CSSC from DMEM, M199, and SCM culture compared to controls, but not in EGM or MethoCult fig. 8G ) and COL1A1 (collagen-I, fig. 8H ) were seen in differentiated cells from all media, but were increased significantly in cells propagated in SCM, EGM and MethoCult, indicating increased ECM production.
Discussion
Corneal reconstruction with amniotic membrane [40, 41] has demonstrated that the acellular amniotic stroma is repopulated by corneal keratocytes that migrate from the stroma through breaks in the Bowman's membrane. These cells are initially CD34 negative but α-SMA and vimentin positive, indicating that they are an "activated" phenotype. When corneal buttons were obtained from corneal grafts performed around 9 to 12 months subsequent to the amniotic membrane graft, several cells in the amnion stroma were positive for CD34, indicating that immunophenotypical transitions occur over time during corneal regeneration in vivo [40] . This holds promise for use of in vitro expanded CSSC in cell therapies for corneal regeneration.
As the potential for the application of regenerative cell therapies for the cornea is realised and research gathers momentum, it is essential that common denominators are established in relation to methodology, so that outcomes are comparable and understood by all. Culture media constituents and respective concentrations can influence cell behaviour and differentiation. Hence, even if we start with an identical cell population, different media and culture environments will result in different cell populations after extended culture, although Our results demonstrate that when an extracted cell population is divided into different media, the resulting cultured cell populations show very different characteristics. Although, some markers such as vimentin, ALDH3A1, CD73 and CD105 were conserved across all media, these markers are associated with fibroblasts and MSC and may potentially be induced by culture on two-dimensional plastic surfaces. This also suggests that the cells fundamentally express a range of baseline markers in vitro, but changing the medium or supplements can cause additional markers to be either maintained or expressed, such as ABCG2, CD34 and PAX6.
Previous media comparison studies have focused solely on the production and maintenance of an MSC phenotype in CSSC [23, 24] , as defined by the ISCT [42] . However, the current minimal criteria for MSC are not ideal for assessing the phenotype of CSSC, as one criterion states that MSC should not express CD34. Nevertheless, our group has showed CD34 is a well-established marker for quiescent keratocytes in vivo [14, 15] , and CD34 has been linked ABCG2 is a molecular determinant of the side population phenotype that is characteristic of stem cells, and has been used previously to identify CSSC [26, 44] . ABCG2 is expressed by a wide variety of stem cells including haematopoietic stem cells [45] , embryonic stem cells [46] , neural stem cells [47] , and perhaps most relevantly limbal epithelial stem cells [48] .
ABCG2 is often downregulated during stem cell differentiation [44] , suggesting that it plays a regulatory role in maintaining stem cells in an undifferentiated state. PAX6, although not conventionally a stem or progenitor marker, is strongly associated with eye development.
PAX6 has also been associated with keratocyte progenitors [49] . SSEA-4 and OCT-4 are markers that are used to identify human pluripotent stem cells [50] . However, these markers have also been found on adult stem cells including MSC [51] . The presence of all these markers on the cells in SCM suggests a level of plasticity, which more differentiated cells may not possess. This plasticity will allow the exploitation of CSSC as cellular therapies, either to repopulate the corneal stroma as keratocytes, or in broader regenerative medicine areas, as they are a readily available and easy to isolate stem cell source. Ingredients within a basal medium can have a large effect on the final cell phenotype.
Comparisons between the DMEM and M199 formulations reveals that M199 contains a number of constituents not found in DMEM including numerous pyrimidines and purines including ATP, ribose, cholesterol and vitamins which likely drive proliferation [54] . M199
contains the same amount of D-glucose as DMEM 'low glucose' formulations (1000 mg/L) whereas the 'high glucose' DMEM used in this study contains significantly higher concentrations (4500 mg/L). This indicates that the much faster proliferation rates seen in M199 compared to DMEM was not down to glucose concentration.
The success of SCM in promoting markers associated with progenitor cells and pluripotency is most likely because it is a medium predominantly used in the culture of human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC). SCM does not contain FBS but instead uses knockout serum replacement (KSR). In cultures of hESC and iPSC, FBS is not suitable as it is an undefined biological product, which varies from batch-to-batch, and can trigger spontaneous differentiation of cells. KSR is chemically defined and the composition can be found in its patent [55] and in this publication by Garcia-Gonzalo and Belmonte [56] .
KSR predominantly contains a mix of amino acids, vitamins, antioxidants, trace elements, insulin, transferrin and lipid-rich albumin, which has been shown to be the ingredient most involved in regulation of pluripotency [56] . SCM also contains the recombinant proteins bFGF and LIF. bFGF is associated with differentiation to the keratocyte phenotype [57] and is essential for the maintenance of pluripotency of hESC [58] . LIF is a factor that is essential in the maintenance of pluripotency in mouse ESC [59] but has also been identified as important in naïve hESC [60] . The combination of these ingredients may allow SCM to induce or maintain a naïve or progenitor phenotype within the CSSC population. SCM was the most successful propagation medium in studies assessing the ability to differentiate back to a keratocyte in vitro. This may be because SCM retained markers associated with the keratocyte phenotype more successfully than the other media types.
From those tested, we have identified SCM as being the medium with the most potential for cell therapy applications; however in its current form it would still not be ideal for the clinical production of CSSC as it is not completely free of animal derived products (xeno-free).
However, all the ingredients have available xeno-free alternatives, which are currently expensive, and would add to the cost of research and clinical translation. It is also worth noting that although the culture medium is important in deriving a phenotype of choice; other aspects of in vitro cell culture can have an effect. Culturing in a three-dimensional environment rather than two-dimensional can help to dedifferentiate cells back to their original form [61] , thus changing to a scaffold based culture method may have an additional effect on top of culture medium. Other changes to the environment can include the use of hypoxia, which has been shown to induce faster proliferation whilst maintaining stem cell potential and delaying the cellular ageing process [62] . However, culture in a threedimensional environment can be complicated and have many unpredictable effects on the This study has shown that there can be considerable variation in the properties of CSSC when cultured in different media. This indicates that in many cases, studies between groups may not be comparable if performed in different media, due to induced variations in final phenotype. For the eventual aim of producing a cell therapy from CSSC, it will be imperative to find a medium that supports a stem cell phenotype and in which the cells can be stably expanded and maintained as stocks in tissue banks, for release when required for clinical use. y 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure 8 . Effect of culture medium on differentiation back to a keratocyte phenotype. CSSC at P3 were differentiated back to a keratocyte phenotype using a serum-free medium containing bFGF, for 21 days. Immunocytochemistry was performed for (A) ALDH3A1, (B) α-SMA, (C) CD34 on non-differentiated control samples (i-v) and differentiated samples (vi-x). CSSC had ben propagated in DMEM, M199, SCM, EGM or MethoCult prior to differentiation. All images shown with DAPI counterstain (blue), scale bar=100 µm. Relative levels of mRNA were determined by RT-qPCR for the following genes (D) ALDH3A1 (E) ACTA2 (F) CD34 (G) KERA and (H) COL1A1. Expression of each target gene is normalised to GAPDH and represented relative to mRNA expression in the non-differentiated control of that media. Data shown as mean±SEM of 3 independent experiments (n=3), each with 2 replicates. Statistical significance vs. control *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001 (two-way ANOVA). 95x150mm (300 x 300 DPI) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
